Evidence map›Paper›PMID 40061173›Full record

ArticleBlood cell therapy2025

Fecal Microbiota Transplantation for Refractory

Pronamee Borah, Vipul Gautam, Vikram Kumar, Bhaskar Saikia, Rahul Naithani

Abstract readCase Reports
In one paragraph

Article in Blood cell therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Haploidentical Hematopoietic Cell Transplants in India.South Asian journal of cancer · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Pronamee BorahHematology and Bone Marrow Transplant Division, Paras Health, Gurugram, India.
Vipul GautamCenter for Liver and Biliary Sciences, Max Superspecialty Hospital, Delhi, India.
Vikram KumarCenter for Liver and Biliary Sciences, Max Superspecialty Hospital, Delhi, India.
Bhaskar SaikiaDepartment of Pediatric Critical Care, Max Superspecialty Hospital, Delhi, India.
Rahul NaithaniHematology and Bone Marrow Transplant Division, Paras Health, Gurugram, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Methods: A 2-year-old child with relapsed acute myeloid leukemia underwent a haploidentical bone marrow transplant. He developed 30-40 episodes/day of loose watery stools on day +19. The stool was positive for Results: Three days later (day +46), stool frequency reduced from 22-24/day to 12-14/day. Color normalized to yellow and consistency improved from watery to semisolid without blood. He was discharged from the hospital 10 days after FMT on oral vancomycin and nasogastric feeding. Stool tested for Conclusion: Fecal microbiota transplant could be a useful modality in children with severe

Indexed as

BMTchildrenClostridioides difficilefecal microbiota transplant

Identifiers

PMID40061173
PMCPMC11883475

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.